Copanlisib in patients with relapsed or refractory follicular lymphoma.

被引：4

作者：

Dreyling, Martin H.

Santoro, Armando

Leppa, Sirpa

Demeter, Judit

Follows, George

Lenz, Georg

Kim, Won Seog

Mollica, Luigina

Nagler, Arnon

Diong, Colin Phipps

Provencio, Mariano

Stevens, Don A.

Trevarthen, David

Magagnoli, Massimo

Cupit, Lisa

Yin, Shuxin

Hiemeyer, Florian

-Vargas, Jose E. Garcia

Childs, Barrett H.

Zinzani, Pier Luigi

机构：

[1] Univ Hosp LMU, Munich, Germany

[2] Humanitas Clin & Res Ctr, Humanitas Canc Ctr, Rozzano, Italy

[3] Helsinki Univ Cent Hosp, Canc Ctr, Helsinki, Finland

[4] Semmelweis Univ, Div Haematol, Dept Internal Med 1, Budapest, Hungary

[5] Cambridge Univ Hosp, Cambridge, England

[6] Munster Univ Clin, Translat Oncol Med Clin, Munster, Germany

[7] Sungkyunkwan Univ, Div Hematol & Oncol, Samsung Med Ctr, Sch Med, Seoul, South Korea

[8] Hop Maison Neuve Rosemont, Montreal, PQ, Canada

[9] Chaim Sheba Med Ctr, Div Hematol, Tel Hashomer, Israel

[10] Singapore Gen Hosp, Dept Haematol, Singapore, Singapore

[11] Univ Autonoma Madrid, Hlth Res Inst, Hosp Univ Puerta Hierro, Madrid, Spain

[12] Norton Canc Inst, Louisville, KY USA

[13] Comprehens Canc Care & Res Inst, Englewood, CO USA

[14] Bayer HealthCare Pharmaceut Inc, Whippany, NJ USA

[15] Bayer AG, Div Pharmaceut, Berlin, Germany

[16] Univ Bologna, Inst Hematol L eA Seragnoli, Bologna, Italy

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷

关键词：

D O I：

10.1200/JCO.2017.35.15_suppl.7535

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

7535

引用

页数：5

共 50 条

[1] Copanlisib for the treatment of adults with relapsed follicular lymphoma
Magagnoli, Massimo
Carlo-Stella, Carmelo
Santoro, Armando
EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (08) : 813 - 823
[2] Rituximab in relapsed follicular lymphoma.
Case, D
Ebrahim, K
Hedlund, J
Boyd, M
Aronson, F
Hayes, D
BLOOD, 2002, 100 (11) : 292B - 292B
[3] Spotlight on copanlisib and its potential in the treatment of relapsed/refractory follicular lymphoma: evidence to date
Mensah, Felix A.
Blaize, Jean-Pierre
Bryan, Locke J.
ONCOTARGETS AND THERAPY, 2018, 11 : 4817 - 4827
[4] EFFICACY AND SAFETY OF COPANLISIB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: A SUBSET ANALYSIS OF THE CHRONOS-1 STUDY
Zinzani, P. L.
Santoro, A.
Leppa, S.
Demeter, J.
Follows, G. A.
Lenz, G.
Kim, W. S.
Mollica, L.
Nagler, A.
Diong, C. P.
Provenciio, M.
Stevens, D. A.
Trevarthen, D.
Maagnoli, M.
Cupit, L.
Yin, S.
Hiemeyer, F.
Garcia-Vargas, J.
Childs, B. H.
Dreyling, M.
HAEMATOLOGICA, 2017, 102 : 314 - 315
[5] Efficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphoma
Panayiotidis, Panayiotis
Follows, George A.
Mollica, Luigina
Nagler, Arnon
Ozcan, Muhit
Santoro, Armando
Stevens, Don
Trevarthen, David
Hiemeyer, Florian
Garcia-Vargas, Jose
Childs, Barrett H.
Zinzani, Pier Luigi
Dreyling, Martin
BLOOD ADVANCES, 2021, 5 (03) : 823 - 828
[6] Treatment selection for patients with relapsed or refractory follicular lymphoma
Skarbnik, Alan Z.
Patel, Krish
FRONTIERS IN ONCOLOGY, 2023, 13
[7] Treatment Selection in Patients With Relapsed or Refractory Follicular Lymphoma
Pagel, John M.
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (12) : 11 - 14
[8] Non-myeloablative allogeneic ifematopoietic transplantation in relapsed/primary refractory follicular lymphoma.
Fabre, C
Recher, C
Huynh, A
Rigal-Huguet, F
Abbal, M
Dastugue, N
Al Saati, T
Brousset, P
Attal, M
BLOOD, 2004, 104 (11) : 635A - 635A
[9] Zanubrutinib - Relapsed or refractory follicular lymphoma
Grant-Monlouis-Felicite, Fiona
Diop, Nadia
BULLETIN DU CANCER, 2024, 111 (06) : 542 - 544
[10] Epcoritamab in Relapsed/ Refractory Follicular Lymphoma
Phillips, Tycel
ONCOLOGY-NEW YORK, 2024, 38 (08):

← 1 2 3 4 5 →